Watch On:
Summary
Working in collaboration with McLean Hospital—America’s top-ranked psychiatric hospital and an affiliate of Harvard Medical School—InStride offers evidence-based treatment that is accessible, affordable and effective. Responding to the rapidly growing pediatric mental health crisis, InStride’s model is based on strong clinical outcomes data and years of hands-on experience. It has been heartbreaking to see how hard it is for families to get help, with too many kids unnecessarily ending up in ERs or inpatient units. Through this innovative care model, InStride is leading the way to provide desperately needed access to more effective treatment of anxiety and OCD.
Show Notes
“There is power in the InStride-McLean collaboration,” said Scott L. Rauch, MD, president and psychiatrist in chief, McLean Hospital.
Healthcare-focused InvestmentInStride also announced it has raised $26M from leading healthcare investors including .406 Ventures, Valtruis and Mass General Brigham Ventures.
McLean Hospital is the largest psychiatric affiliate of Harvard Medical School and a member of the Mass General Brigham healthcare system.
ABOUT MASS GENERAL BRIGHAM VENTURESMass General Brigham Ventures is an early-stage venture firm focused on investing in new life science technologies that emerge from the Mass General Brigham hospital research community.
SOURCE InStride Health
